DuPont Nutrition & Health announced a significant investment to expand probiotics production capacity in the United States.
The investment is the second phase of a broader probiotics expansion project due to the rapidly growing global demand for probiotics.
Phase One, supporting current growth, is ongoing in Madison, Wis., and Rochester, N.Y., and will be partially complete by the end of 2016.
The second phase is scheduled to span two-years, represents an investment of approximately $100 million, and increases the company’s probiotics production capacity by an additional 70 percent. Production will be optimized with the installation of new, high-volume fermenters and other processing equipment.
“This investment reinforces our commitment to the probiotics industry. We see strong growth worldwide, and increasing our capacity enables our partners to continue growing and capturing the opportunities from very favorable market trends,” said Matthias Heinzel, president, DuPont Nutrition & Health. “As we phase in more capacity, we will continue to maintain the high potency, stability and efficacy in our products that have made DuPont the global probiotics leader. Quality is extremely important in probiotic production, and our reputation for manufacturing quality has always been a differentiator with DuPont probiotics.”
Probiotics have seen rapid adoption. In the United States, consumer awareness is at an all-time high (75 percent), according to the Natural Marketing Institute.
Further evidence of worldwide probiotic acceptance is reflected in Euromonitor data that shows an increase in the compound annual growth rate for 2015 to 2020 in every global region – from 4.5 percent in Asia Pacific to 26 percent in South America.
Health-conscious consumers are addressing personal health concerns by including probiotics in their daily health and wellness routines. “Consumers want to proactively take care of their health, and they’re increasingly turning to probiotics to fill that need,” said John Rea, global business unit leader for Probiotics, Cultures, Food Protection and HMOs. “We have found through proprietary research that consumers feel probiotics offer a great way to improve their overall health and wellness. And they see probiotics playing the role of a ‘balancer’ in the midst of a stress-filled, fast-paced lifestyle.”
For more than 30 years, DuPont Nutrition & Health has been a global leader in the science, research and production of probiotics.
Today DuPont continues that tradition with microbiome work, researching novel uses of probiotics for health and wellness. DuPont™ Danisco® HOWARU® premium probiotics and FloraFit® custom probiotics, which are used in food, beverage, dietary supplement and animal nutrition products, are produced at the Rochester location.
The broad portfolio of DuPont probiotic strains is backed by comprehensive clinical studies and documentation, showing efficacy in the support of immune and digestive health. DuPont probiotics offer customers:
- The widest range of stable, clinically documented probiotics
- Application in novel delivery formats
- Specialized sales and technical support
- Expert legal and regulatory support
- Finished product format options
DuPont Nutrition & Health combines in-depth knowledge of food and nutrition with current research and expert science to deliver unmatched value to the food, beverage and dietary supplement industries.
folio to help our customers turn challenges into high-value business opportunities.
We are innovative solvers, drawing on deep consumer insights and a broad product port DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802. The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment.
 DuPont proprietary research conducted by 20/20 Research, Inc., May 2015.